Tracing Method Studies Circulating Tumour Cells in Lung Cancer Patients

Technique to examine circulating tumour cells in the blood of patients with non-small cell lung cancer has been devised by researchers. This method, which can analyze a sample size as small as three cells, may allow clinicians to track cancer progress and treatments and could help them develop new therapies.

"We have developed an extremely sensitive test that could be able to detect mutations present in circulating tumor cells (CTCs), and we are hoping that from their characterization, we would be able to understand diagnostic, prognostic and predictive markers," said Heidi S. Erickson, Ph.D., assistant professor of thoracic/head and neck medical oncology at the University of Texas MD Anderson Cancer Center.

Lung Cancer - Types, Causes, Symptoms, Diagnosis, Treatment and Prevention
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.

Erickson presented the findings at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012.

Even though researchers have found that the presence of CTCs in the blood of patients with lung cancer is associated with short survival, clinicians have had no way to analyze the actual CTCs because their levels were so small.

In this study, Erickson and colleagues showed the effectiveness of using high-throughput matrix-assisted laser desorption/ionization time-of-flight mass spectrometry single nucleotide polymorphism analysis (MALDI-TOF MS SNP) — an extremely sensitive analysis using a mass spectrometer — to analyze and determine the exact genetic mutations present in DNA from a few malignant cells that can be applied to CTC samples.

Lung Cancer Screening - FAQs
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible cure.

Identifying these mutations would allow clinicians to track progress of genetic changes and thus monitor the cancer and the effectiveness of any treatments being administered. It could also enable researchers to identify ways in which the cancer develops and possibly identify new therapy targets. This analysis method also benefits the patient in the way samples are taken.

"By being able to collect a blood sample from a patient instead of having to do a biopsy, we'll have an opportunity to monitor the patient throughout treatment in an easier way," said Erickson.

Lung Biopsy - Indications - Procedures - Risks - FAQs - Reference
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy tissues obtained from the lungs are examined by a pathologist.

The researchers showed the method works by "spiking" a blood sample with a cell line containing a known specific mutation. They then used the MALDI-TOF MS SNP method to test the sample and found the cancer cell line mutation they had used.

Collection and purification methods of CTC samples are not yet perfected. When they are, the researchers will test samples from actual patients with lung cancer, Erickson said.

Trained Sniffer Dogs Help to Screen Lung Cancer
Scientists in Germany have discovered that sniffer dogs are very reliable when it comes to detecting lung cancer.

Source-Eurekalert